NCT03261544 Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
| NCT ID | NCT03261544 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Sarcoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2017-11-10 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2017-11-10 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to assess the functional outcomes in patients undergoing proximal femur resection and reconstruction with an endoprosthesis, based on the abductor muscle repair technique. The investigators hypothesize that those patients who receive reattachment of the abductors directly into the prosthesis will have better functional outcomes overall. Furthermore, the investigators plan to develop a simple, cost effective, and reproducible method to assess abductor function at clinical post-operative visits through plain radiographs.
Eligibility Criteria
Inclusion Criteria: • Has undergone or is scheduled for proximal femur replacement by an Ortho Oncology surgeon Exclusion Criteria: * Non-ambulatory before or after the procedure * Subjects who, in the opinion of the investigator, have not or likely will not complete at least some portion of the investigator's recommended follow-up
Contact & Investigator
William Eward, MD, DVM
PRINCIPAL INVESTIGATOR
Duke University
Frequently Asked Questions
Who can join the NCT03261544 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 75 Years, studying Sarcoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03261544 currently recruiting?
Yes, NCT03261544 is actively recruiting participants. Contact the research team at elizabeth.sachs@duke.edu for enrollment information.
Where is the NCT03261544 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT03261544 clinical trial?
NCT03261544 is sponsored by Duke University. The principal investigator is William Eward, MD, DVM at Duke University. The trial plans to enroll 50 participants.